Bioceres Crop Solutions Corp. (BIOXD.BA)
- Previous Close
4.3000 - Open
4.3550 - Bid 4.3200 x --
- Ask 4.8500 x --
- Day's Range
4.3200 - 4.3600 - 52 Week Range
3.4800 - 14.7500 - Volume
85 - Avg. Volume
1,958 - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.60
- PE Ratio (TTM)
-- - EPS (TTM)
-4.6680 - Earnings Date Feb 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
investors.biocerescrops.com/home/default.aspx--
Full Time Employees
June 30
Fiscal Year Ends
--
Sector
--
Industry
Recent News: BIOXD.BA
View MorePerformance Overview: BIOXD.BA
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BIOXD.BA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIOXD.BA
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.37%
Return on Assets (ttm)
2.47%
Return on Equity (ttm)
0.62%
Revenue (ttm)
407.73M
Net Income Avi to Common (ttm)
1.5M
Diluted EPS (ttm)
-4.6680
Balance Sheet and Cash Flow
Total Cash (mrq)
31.2M
Total Debt/Equity (mrq)
82.48%
Levered Free Cash Flow (ttm)
-22.36M